|
Volumn 51, Issue 4, 2009, Pages 324-326
|
The story of antipsychotics: Past and present
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZAMIDE DERIVATIVE;
BUTYROPHENONE DERIVATIVE;
CHLORPROMAZINE;
CLOZAPINE;
DEXTROMORAMIDE;
FLUPHENAZINE;
HALOPERIDOL;
IMIPRAMINE;
NARCOTIC ANALGESIC AGENT;
NEUROLEPTIC AGENT;
OLANZAPINE;
PHENOTHIAZINE DERIVATIVE;
PLACEBO;
PROMETHAZINE;
QUETIAPINE;
RISPERIDONE;
THIORIDAZINE;
TRIFLUOPERAZINE;
ZIPRASIDONE;
AGRANULOCYTOSIS;
BIPOLAR DISORDER;
BLOOD DYSCRASIA;
CLINICAL TRIAL;
CONVULSIVE THERAPY;
DROWSINESS;
DRUG ACTIVITY;
DRUG DOSE INCREASE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
ELECTROCONVULSIVE THERAPY;
EXTRAPYRAMIDAL SYMPTOM;
GILLES DE LA TOURETTE SYNDROME;
HUMAN;
HYPERSALIVATION;
HYPOTENSION;
INSULIN TREATMENT;
MANIA;
MORTALITY;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUROLOGIC DISEASE;
NONHUMAN;
PARANOID PSYCHOSIS;
PSYCHOSIS;
SCHIZOPHRENIA;
SEIZURE THRESHOLD;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT RESPONSE;
|
EID: 77953450593
PISSN: 00195545
EISSN: 19983794
Source Type: Journal
DOI: 10.4103/0019-5545.58304 Document Type: Short Survey |
Times cited : (39)
|
References (3)
|